Prostate cancer ▲ Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)

PROSTATE CANCER

Last Updated: Sep 08, 2016

• Advances in genetics: widening our understanding of prostate cancer.
  Pine Angela C et al. F1000Research 2016 5
• Prostate Cancer Awareness 
• Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.
  Wang Kewei, et al. BMC cancer 2016 0 (1) 674
• The association between MMP2 -1306 C > T (rs243865) polymorphism and risk of prostate cancer.
  Shajarehpoor Salavati L, et al. Irish journal of medical science 2016 8
• Use of a novel non-parametric version of DEPTH to identify genomic regions associated with prostate cancer risk.
  MacInnis Robert J, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 8
• A comprehensive analysis of genome-wide association studies to identify prostate cancer susceptibility loci for the Romanian population.
  R?d?voi George Daniel, et al. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2016 0 (2) 467-75
• Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies.
  Jiang Xiao, et al. OncoTargets and therapy 2016 0 4491-503
• Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance.
  Shu Xiang, et al. Carcinogenesis 2016 8
• Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
  Kerns Sarah L, et al. EBioMedicine 2016 7
• Stakeholder consultation insights on the future of genomics at the clinical-public health interface.
  Modell Stephen M et al. Translational research : the journal of laboratory and clinical medicine 2014 May 163(5) 466-77
• eNOS gene polymorphisms in paraffin-embedded tissues of prostate cancer patients.
  Polat Fikriye, et al. Turkish journal of medical sciences 2016 0 (3) 673-9
• Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients.
  Kachakova Darina, et al. Turkish journal of medical sciences 2016 0 (3) 626-40
• Genetic variants in RNA-induced silencing complex genes and prostate cancer.
  Nikoli? Z, et al. World journal of urology 2016 8
• Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
  Karunasinghe Nishi, et al. BMC urology 2016 0 (1) 48
• Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African-Americans.
  Koboldt Daniel C, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 8

• CDC Information (3)
• CDC-Authored Pub (1)

• Human (17)
• Pathogen (1)

• Human (2062)
• Pathogen (0)

• Human (82)
• Pathogen (0)

• Guidelines (1)
• Tier Table (1)
• Synthesis (8)

• Huamn (5)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB